CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-04 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $396.54 | $79K | 36,781 |
| 2025-09-04 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 66,000 | ||
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −11,375 | $419.63 | $4.8M | 3,250 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −106 | $405.59 | $43K | 3,144 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −500 | $407.34 | $204K | 2,644 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −700 | $408.97 | $286K | 1,944 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,144 | $409.97 | $469K | 800 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −168 | $412.69 | $69K | 632 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −32 | $413.39 | $13K | 600 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −200 | $416.30 | $83K | 400 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −328 | $418.03 | $137K | 72 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −72 | $419.35 | $30K | 0 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −888 | $407.26 | $362K | 6,987 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −300 | $408.28 | $122K | 6,687 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −100 | $410.35 | $41K | 6,587 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −367 | $417.45 | $153K | 6,220 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −95 | $419.61 | $40K | 6,125 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −6,125 | $419.63 | $2.6M | 0 |
| 2025-09-02 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 172,875 |
Page 205 of 214 · 4,273 trades